Gastric-type Endocervical Adenocarcinoma: a Population-based Cohort Study

NCT06897306 | Completed

• 1 other identifier: SYSKY-2025-057-01
• Study Type: observational
• Target: 317
• Locations: 1 country
• Sites: 1

Brief Summary

This study aims to collect data of patients with Gastric-type Endocervical Adenocarcinoma from the SEER database, analyze the related prognostic factors and treatment patterns of Gastric-type Endocervical Adenocarcinoma, and explore the impact of surgical treatment on the prognosis of locally advanced Gastric-type Endocervical Adenocarcinoma.

Conditions

Uterine Cervical Neoplasms; Surgery; Therapy; Locally Advanced Cervical Carcinoma

Keywords

Uterine Cervical Neoplasms; cervical cancer; Gastric - type Mucinous Adenocarcinoma; surgery

Outcome Measures

Primary Outcomes (1)

• Overall survival (OS)

  The time from diagnosis to death of the patient.

  The time from diagnosis to death of the patient，Assessed up to 227 months

Secondary Outcomes (1)

• Vital status recode(study cutoff used)

  up to 227 months

Interventions

surgery PROCEDURE

The patient underwent surgery.

Eligibility Criteria

• Sex: female
• Healthy Volunteers: No
• Age Groups: Child (0-17), Adult (18-64), Older Adult (65+)
• Sampling Method: Non-Probability Sample

Study Population

The Surveillance, Epidemiology, and End Results (SEER) database is a comprehensive source of population - based cancer incidence and survival data in the United States. The population covered by the SEER database is diverse and representative of the broader U.S. population. It includes individuals from various racial and ethnic backgrounds, age groups, and geographic regions. The data are collected from 17 population - based cancer registries, which cover approximately 28% of the U.S. population. This allows for the analysis of cancer - related outcomes and trends across different demographic and socioeconomic groups, providing valuable insights into the burden of cancer and the effectiveness of cancer - related interventions in a population - based setting.

You may qualify if:

• Patients diagnosed with Gastric - type Endocervical Adenocarcinoma were identified using the SEER database and SEER\*Stat 8.4.2 software. The search scope was the "SEER Research Plus Data, 17 Registries, Nov 2021 sub (2000 - 2019)" database. The screening criteria included "Site and Morphology, Analytic Behavior Recode = Malignant" and "Site and Morphology, ICD - O - 3 / WHO 2008 Recode Site = Cervix". Patients with Gastric - type Endocervical Adenocarcinoma in the database were selected.

You may not qualify if:

• Patients with a survival time of 0 or unknown.

Sponsors & Collaborators

• Sun Yat-Sen Memorial Hospital of Sun Yat-Sen University: lead

Study Sites (1)

The Sun Yat-Sen Memorial Hospital of Sun Yat-Sen Universit

Guangzhou, Guangdong, China

Location

MeSH Terms

Conditions

Uterine Cervical Neoplasms

Interventions

Surgical Procedures, Operative

Condition Hierarchy (Ancestors)

Uterine Neoplasms; Genital Neoplasms, Female; Urogenital Neoplasms; Neoplasms by Site; Neoplasms; Uterine Cervical Diseases; Uterine Diseases; Genital Diseases, Female; Female Urogenital Diseases; Female Urogenital Diseases and Pregnancy Complications; Urogenital Diseases; Genital Diseases

Study Officials

• Huaiwu Lu

  The Sun Yat-Sen Memorial Hospital of Sun Yat-Sen University

  STUDY DIRECTOR

Study Design

• Study Type: observational
• Observational Model: COHORT
• Time Perspective: RETROSPECTIVE
• Sponsor Type: OTHER
• Responsible Party: SPONSOR

Study Record Dates

• First Submitted: February 6, 2025
• First Posted: March 26, 2025
• Study Start: October 1, 2024
• Primary Completion: November 1, 2024
• Study Completion: January 20, 2025
• Last Updated: March 26, 2025

Record last verified: 2025-02

Locations

CN (1)